Evidence map›Paper›PMID 25961887›Full record

ReviewJAMA neurology2015

Neuroelectronics and Biooptics: Closed-Loop Technologies in Neurological Disorders.

Esther Krook-Magnuson, Jennifer N Gelinas, Ivan Soltesz, György Buzsáki

Open access · hybridAbstract readReview
In one paragraph

Review in JAMA neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 95 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Implantable bioelectronic outlet.Science advances · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. E-Suture: Mixed-Conducting Suture for Medical Devices.Advanced healthcare materials · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Esther Krook-MagnusonDepartment of Neuroscience, University of Minnesota, Minneapolis.
Jennifer N GelinasNew York University Neuroscience Institute, Langone Medical Center, New York3New York University Center for Neural Sciences, New York.
Ivan SolteszDepartment of Anatomy and Neurobiology, University of California, Irvine.
György BuzsákiNew York University Neuroscience Institute, Langone Medical Center, New York3New York University Center for Neural Sciences, New York.
NYU Langone Health · USUniversity of California, Irvine · USUniversity of Minnesota · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
The Hippocampal Interneuron NetworkR01MH054671 · NIMH · RUTGERS THE STATE UNIV OF NJ NEWARK · PI BUZSAKI, GYORGY · 1997 to 2017
$5.2M
Towards a Complete Description of the Circuitry Underlying Memory replay.U01NS090583 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SOLTESZ, IVAN · 2014 to 2016
$2.1M
Deducing the origin and effect of extracellular electric fields in hippocampusR01NS074015 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI KOCH, CHRISTOF · 2011 to 2015
$1.7M
GABAergic regulation of entorhino-hippocampal excitability in epilepsy.R01NS074432 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI SOLTESZ, IVAN · 2011 to 2015
$1.6M
On-demand optogenetic cerebellar intervention for temporal lobe epilepsyK99NS087110 · NINDS · UNIVERSITY OF CALIFORNIA-IRVINE · PI KROOK-MAGNUSON, ESTHER · 2014 to 2014
$90k
NICHD NIH HHS K12 HD000850NIMH NIH HHS MH54671NIMH NIH HHS R01 MH054671NINDS NIH HHS K99 NS087110NINDS NIH HHS K99NS087110NINDS NIH HHS NS074015NINDS NIH HHS NS090583NINDS NIH HHS NS74432NINDS NIH HHS R01 NS074015NINDS NIH HHS R01 NS074432NINDS NIH HHS U01 NS090583
6 · The paper itself

Abstract

Brain-implanted devices are no longer a futuristic idea. Traditionally, therapies for most neurological disorders are adjusted based on changes in clinical symptoms and diagnostic measures observed over time. These therapies are commonly pharmacological or surgical, requiring continuous or irreversible treatment regimens that cannot respond rapidly to fluctuations of symptoms or isolated episodes of dysfunction. In contrast, closed-loop systems provide intervention only when needed by detecting abnormal neurological signals and modulating them with instantaneous feedback. Closed-loop systems have been applied to several neurological conditions (most notably epilepsy and movement disorders), but widespread use is limited by conceptual and technical challenges. Herein, we discuss how advances in experimental closed-loop systems hold promise for improved clinical benefit in patients with neurological disorders.

Indexed as

Electrodes, ImplantedBrainDeep Brain StimulationHumansNervous System DiseasesOptogenetics

Identifiers

PMID25961887
PMCPMC4501886
OpenAlexW1534009784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.